Cisplatin/Carboplatin and Etoposide With or Without Nivolumab in Treating Patients With Extensive Stage Small Cell Lung Cancer

NCT03382561 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

160

Enrollment

NIH

Sponsor class

Conditions

Extensive Stage Lung Small Cell Carcinoma
Recurrent Lung Small Cell Carcinoma

Interventions

DRUG: Carboplatin
DRUG: Cisplatin
DRUG: Etoposide
BIOLOGICAL: Nivolumab

Sponsor

National Cancer Institute (NCI)